Skip to main content
    L

    Lifestance Health Group Inc (LFST)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $14.17
    -0.31 (-2.14%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Lifestance Health Group Inc (LFST) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Lifestance Health Group (LFST) has a market cap of $5.35B and an enterprise value of $5.39B. Revenue grew 22.62% over the last 12 months from the 12 months before. Its return on invested capital of 4.57% compares with a 12.96% median across 10 similar companies.

    Total Valuation

    Enterprise value is 0.69% above the market cap, as debt exceeds cash.

    Market Cap$5.35B
    Enterprise Value$5.39B
    Latest price (Nov 17, 2026)$14.17

    Key Dates

    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.60% in the quarter ended Sep 30, 2026 and grew 0.11% a year over 2 years.

    Shares Outstanding381.21M
    Shares Change (YoY)-1.49%
    Shares Change (QoQ)-0.60%
    Share Count Growth (2Y CAGR)+0.11%

    Valuation Ratios

    Sales and book value multiples are 3.2x and 3.6x.

    P/E Ratio50.9x
    Forward P/E80.9x
    P/S Ratio3.2x
    Forward P/S3.1x
    P/B Ratio3.6x
    P/TBV Ratio318.5x
    P/FCF Ratio30.1x
    P/OCF Ratio23.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 34.7x EBITDA and 30.3x free cash flow.

    EV / Earnings75.0x
    EV / Sales3.2x
    EV / EBITDA34.7x
    EV / EBIT54.1x
    EV / FCF30.3x

    Price Statistics

    The stock is up 121.41% over 52 weeks and trades 10.27% above its 50-day average.

    Beta (1Y)0.85
    52-Week Change+121.41%
    1-Month Change+20.39%
    3-Month Change+10.44%
    6-Month Change+83.31%
    5-Year Change+11.85%
    Total Return (1Y)+121.41%
    Total Return (3Y CAGR)+31.93%
    Total Return (5Y CAGR)+10.08%
    Return vs SPY (1Y)+116.99%
    Max Drawdown (1Y)-17.06%
    Max Drawdown (3Y)-56.49%
    Sharpe Ratio (1Y)1.90
    Correlation with SPY (1Y)0.27
    50-Day Average$12.85
    200-Day Average$9.75
    52-Week Range$6.05 to $15.66
    RSI (14 Days)59.2
    Average Volume (20 Days)6.87M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.44x current liabilities, and total debt is 0.17x shareholder equity.

    Current Ratio1.44x
    Quick Ratio1.44x
    Debt / Equity0.17x
    Debt / EBITDA1.63x
    Debt / FCF1.43x
    Interest Coverage10.18x

    Returns and Efficiency

    Return on invested capital is 4.57% over the last 12 months, against a 5-year average of -7.50%.

    Return on Equity (ROE)4.82%
    Return on Assets (ROA)3.29%
    Return on Invested Capital (ROIC)4.57%
    Return on Capital Employed (ROCE)5.18%
    ROE (5Y Average)-10.09%
    ROA (5Y Average)-7.39%
    ROIC (5Y Average)-7.50%
    Asset Turnover0.77x
    Receivables Turnover14.46x

    Taxes

    Income tax took 19.94% of pretax income over the last 12 months.

    Income Tax (TTM)$17.91M
    Effective Tax Rate19.94%

    Scores

    LFST has an Altman Z-Score of 5.17, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score5.17
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $1.68B over the last 12 months.

    Revenue$1.68B
    Revenue Growth (YoY)+22.62%
    Gross Profit$1.68B
    Operating Income$104.10M
    Pretax Income$89.82M
    Net Income$71.91M
    EBITDA$156.66M
    EBIT$99.71M
    Reported EPS (TTM)$0.28

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 68.04% of the $2.19B in total assets.

    Cash and Equivalents$218.82M
    Total Debt$255.52M
    Net Debt$36.71M
    Net Debt Per Share$0.10
    Working Capital$115.65M
    Shareholder Equity$1.49B
    Book Value Per Share$3.91
    Tangible Book Value$16.96M
    Tangible Book Per Share$0.04
    Total Assets$2.19B
    Total Liabilities$693.89M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $48.33M of capital spending, operating cash flow left $179.27M of free cash flow.

    Operating Cash Flow$227.60M
    Capital Expenditures$48.33M
    Free Cash Flow$179.27M
    FCF Per Share$0.47
    Depreciation and Amortization$56.95M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 6.21%, against a 5-year average of -17.22%.

    Gross Margin100.00%
    Operating Margin6.21%
    Pretax Margin5.36%
    Net Margin4.29%
    EBITDA Margin9.34%
    EBIT Margin5.95%
    FCF Margin10.69%
    Operating Margin (5Y Average)-17.22%
    Net Margin (5Y Average)-18.53%

    Growth

    Revenue grew 18.33% a year over 3 years.

    Revenue Growth (3Y CAGR)+18.33%
    Revenue Growth (5Y CAGR)+30.44%
    Book Value Per Share Growth (2Y CAGR)+0.35%

    Revenue and profit by year

    Dividends and Yields

    LFST does not pay a dividend. Its free cash flow yield is 3.32%.

    Earnings Yield1.96%
    FCF Yield3.32%
    Buyback Yield2.27%
    Shareholder Yield2.27%

    Peer Position

    Against 12 similar companies, LFST has the 2nd highest P/E and the highest P/S.

    P/E Ratio50.9x vs 23.6x median
    P/S Ratio3.2x vs 1.2x median
    ROIC4.57% vs 12.96% median
    Revenue Growth (Trailing 4 Quarters, YoY)+22.62% vs +8.68% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 18.05% and EPS growth at 80.01% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+18.05%
    EPS Growth Forecast (2Y CAGR)+80.01%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LFST

    What is LFST's market cap?

    Lifestance Health Group has a market cap of $5.35B. Its enterprise value, which adds debt and subtracts cash, is $5.39B.

    What is LFST's P/E ratio?

    Lifestance Health Group has a trailing P/E ratio of 50.9x and a forward P/E of 80.9x.

    How many shares of LFST are outstanding?

    Lifestance Health Group has 381.21M shares outstanding. The count is down 1.49% from a year earlier.

    Does LFST pay a dividend?

    No. Lifestance Health Group does not pay a dividend.

    How much debt does LFST have?

    Lifestance Health Group has $255.52M of total debt and $218.82M of cash and equivalents, a net debt position of $36.71M.